5AM Ventures IV, L.P.
CIK 1589315 · last filed 2022-10-11
5AM Ventures IV, L.P. is a corporate insider who has filed 6 SEC Form 4 insider transactions across 5 companies since 2018. The most recent filing shows the insider sold $19.9M of SCPH on Oct 11, 2022. Across all open-market trades the lifetime net is −$190.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $5.3M across reported positions. The firm reports its address in San Francisco, CA. 35 SEC filings were submitted jointly with 5AM Co-Investors IV, L.P.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
IDYA price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
SAN FRANCISCO, CA 94111
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| scPharmaceuticals Inc. (SCPH) Delisted | 10%+ Owner | 2,688,014 | $5.67 | $15.24M | -$28.69M | 2 | 2022-10-11 |
| IDYA | 10%+ Owner | 91,142 | $32.88 | $3.00M | -$87.42M | 1 | 2020-11-13 |
| APRE | 10%+ Owner | 16,667 | $0.45 | $7.5K | -$71.71M | 1 | 2020-05-21 |
| Crinetics Pharmaceuticals, Inc. (CRNX) Delisted | 10%+ Owner | 1,723 | $84.95 | $146.4K | $0 | 1 | 2019-02-22 |
| FIXX | 10%+ Owner | 328,049 | $6.93 | $2.27M | -$2.43M | 1 | 2018-12-12 |
Recent Filings
6 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-10-11 | scPharmaceuticals Inc. (SCPH) Delisted | Sell (S) | −4,800,000 | -$19.91M | EDGAR |
| 2022-09-08 | scPharmaceuticals Inc. (SCPH) Delisted | Sell (S) | −1,812,976 | -$8.78M | EDGAR |
| 2020-11-13 | IDYA | Sell (S) | −6,400,000 | -$87.42M | EDGAR |
| 2020-05-21 | APRE | Sell (S) | −2,040,000 | -$71.71M | EDGAR |
| 2019-02-22 | Crinetics Pharmaceuticals, Inc. (CRNX) Delisted | Other (J) | −2,788,986 | $0 | EDGAR |
| 2018-12-12 | FIXX | Sell (S) | −93,450 | -$2.43M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.